Market Overview

UPDATE: JP Morgan Upgrades Thermo Fisher Scientific to Overweight on Favorable Risk/Reward

Share:
Related TMO
Deutsche Bank Optimistic On Fundamentals In Life Science Tools/Diagnostics Sector
10 Notable Stocks Trading Ex-Dividend Tuesday, December 13
Athena Capital Advisors Llc Buys Simon Property Group Inc, SPDR S&P 5……, iShares Select ... (GuruFocus)

JP Morgan upgraded Thermo Fisher Scientific (NYSE: TMO) from Neutral to Overweight and raised the price target from $70.00 to $80.00.

JP Morgan noted, "We are upgrading Thermo Fisher Scientific (TMO) from Neutral to Overweight on favorable risk/reward due to conservative guidance that should be at worst achievable, and more likely beatable, and an improving record of capital deployment since management has increasingly focused on the higher bar of ROIC, rather than simply adjusted EPS accretion. The company's robust and growing free cash flow provides clear optionality around additional capital deployment, including but not limited to recent press reports (Reuters) that it is now evaluating a purchase of Life Technologies (LIFE)."

Thermo Fisher Scientific closed at $72.14 on Thursday.

Latest Ratings for TMO

DateFirmActionFromTo
Jan 2017Deutsche BankInitiates Coverage OnBuy
Jan 2017Deutsche BankInitiates Coverage OnBuy
Nov 2016Leerink SwannAssumesOutperform

View More Analyst Ratings for TMO
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Upgrades Analyst Ratings

 

Related Articles (TMO)

View Comments and Join the Discussion!